Vaccine Therapy and Celecoxib in Treating Patients With Metastatic Nasopharyngeal Cancer

Summary

RATIONALE: Vaccines made from a gene-modified virus and a person's dendritic cells may help the body build an effective immune response to kill tumor cells. Celecoxib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving vaccine therapy together with celecoxib may kill more tumor cells. PURPOSE: This phase II trial is studying how well giving vaccine therapy together with celecoxib works in treating patients with metastatic nasopharyngeal cancer.

Timeline

Start

2007-11

Primary completion

2009-12

Completion

—

Drugs

Indications